Follow-The-Filings

Security · featured owners

MRNA Moderna Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.2%
  • $140M
  • 2 new

MRNA (Moderna Inc.) is held in 2 featured 13F books as of 2026 Q2. Ron Baron - Bamco Inc. (Baron Capital) is the largest tracked holder by portfolio weight (0.21%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Ron Baron - Bamco Inc. (Baron Capital)) · not free-float ownership

  1. Ron Baron new 0.21%
  2. Murphy Pohlad new 0.09%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.21% New 0.21% 1,989,386 $139M history
Murphy Pohlad - Murphy Pohlad Asset Management 2026 Q2 0.09% New 0.09% 3,824 $268K history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 5 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 10, 2026 Filing Doc
4 Period Sep 4, 2026 · 2 forms Filing Doc
4 Period Sep 1, 2026 · 3 forms Filing Doc
4 Period Aug 27, 2026 · 3 forms Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 8, 2026 Filing Doc
4 Period Jul 5, 2026 Filing Doc
4 Period Jul 2, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 5, 2026 Filing Doc
4 Period Jun 4, 2026 Filing Doc
4 Period Jun 1, 2026 · 3 forms Filing Doc
4 Period May 27, 2026 · 3 forms Filing Doc
4 Period May 21, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc

Updated about 13 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.85B $3.24B $1.94B
Gross profit * $2.16B $1.77B $1.08B
Gross margin * 31.5% 54.8% 55.3%
Net income -$4.71B -$3.56B -$2.82B
Net margin * -68.8% -110.0% -145.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $10.32B $8.1B $6.54B
Total non-current assets * $8.1B $6.04B $5.79B
Total assets $18.43B $14.14B $12.34B
Total current liabilities $3.02B $2.21B $1.99B
Total non-current liabilities * $1.56B $1.04B $1.7B
Total equity $13.85B $10.9B $8.65B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$3.12B -$3B -$1.87B
Cash from investing $4.21B $1.95B $1.95B
Cash from financing -$1.38B $0.056B $0.593B
Net change in cash -$289M -$999M $668M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders